Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-27

Clinical Trial Update: Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

View source ↗

Summary

The study on collection of cerebrospinal fluid and tumor tissue in subjects with metastatic melanoma and controls has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Metastatic Melanoma, CNS Metastases | Status: WITHDRAWN